Epidemiology, diagnosis, treatment, and prevention of cerebrospinal fluid shunt infections.
Soon after cerebrospinal fluid (CSF) shunts became available in the late 1950s, infection was recognized as a serious complication of their use, although the bacterial cause of the infections and the way in which they arose was not clarified for a number of years. Subsequent research has since revealed their etiology and provided data that have improved the understanding of aspects of diagnosis, treatment, and prevention.
Bayston
R
R
Biomaterials-Related Infection Group, Division of Microbiology and Infectious Diseases, University of Nottingham, City Hospital, Nottingham NG5 1PB, England. roger.bayston@nottingham.ac.uk
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D002557:Cerebrospinal Fluid Shunts / Q000295:instrumentation*; D003430:Cross-Sectional Studies; D020878:Device Removal; D006801:Humans; D011183:Postoperative Complications / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D012307:Risk Factors
D000900:Anti-Bacterial Agents